Abstract
In bipolar patients, maintenance treatment with anticonvulsive agents is a valid alternative to lithium. These agents have widely varying mechanisms of action. Some of these medications focus on the current understanding of antiglutamatergic mechanisms of action and their treatment implications for bipolar disorders.
Keywords: glutamate, anticonvulsants, depression, bipolar disorder
Current Drug Targets
Title: The Role of Newer Antiglutamatergic Agents as Mood-Stabilizers in Bipolar Disorder
Volume: 6 Issue: 5
Author(s): Marianna Abelli, Claudia Martini, Stefano Pini, Camilla Gesi and Giovanni B. Cassano
Affiliation:
Keywords: glutamate, anticonvulsants, depression, bipolar disorder
Abstract: In bipolar patients, maintenance treatment with anticonvulsive agents is a valid alternative to lithium. These agents have widely varying mechanisms of action. Some of these medications focus on the current understanding of antiglutamatergic mechanisms of action and their treatment implications for bipolar disorders.
Export Options
About this article
Cite this article as:
Abelli Marianna, Martini Claudia, Pini Stefano, Gesi Camilla and Cassano B. Giovanni, The Role of Newer Antiglutamatergic Agents as Mood-Stabilizers in Bipolar Disorder, Current Drug Targets 2005; 6 (5) . https://dx.doi.org/10.2174/1389450054546015
DOI https://dx.doi.org/10.2174/1389450054546015 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clonal Expansion of Mitochondrial DNA Deletions and the Progression of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Quality of Life of Children with Cerebral Palsy: A Cross-Sectional KIDSCREEN study in the Southern part of the Netherlands
CNS & Neurological Disorders - Drug Targets Protective Effects of the Caffeine Against Neurodegenerative Diseases
Current Medicinal Chemistry Regulatory Cascade of Neuronal Loss and Glucose Metabolism
CNS & Neurological Disorders - Drug Targets Neuroimaging of Consciousness and Sleep Spindles
Recent Patents on Medical Imaging [General Articles] Cannabinoids: Mechanisms and Therapeutic Applications in the CNS
Current Medicinal Chemistry Towards a Unified Theory of Calmodulin Regulation (Calmodulation) of Voltage-Gated Calcium and Sodium Channels
Current Molecular Pharmacology In Vivo MRI in Different Models of Experimental Epilepsy
Current Drug Targets Theory and Application of Microdialysis in Pharmacokinetic Studies
Current Drug Metabolism Current & Future Therapies of Erectile Dysfunction in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) High Mobility Group Box-1 (HMGB1): A Potential Target in Therapeutics
Current Drug Targets Melatonin Receptor Agonists: SAR and Applications to the Treatment of Sleep-Wake Disorders
Current Topics in Medicinal Chemistry Regulation of miRNA Processing and miRNA Mediated Gene Repression in Cancer
MicroRNA The Role of mGlu Receptors in Hippocampal Plasticity Deficits in Neurological and Psychiatric Disorders: Implications for Allosteric Modulators as Novel Therapeutic Strategies
Current Neuropharmacology Nanobiotechnological Approaches Against Multidrug Resistant Bacterial Pathogens: An Update
Current Drug Metabolism Metabotropic Glutamate Receptors in the Trafficking of Ionotropic Glutamate and GABAA Receptors at Central Synapses
Current Neuropharmacology Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives
Current Pharmaceutical Design Patent Annotations
Recent Patents on Anti-Cancer Drug Discovery Statins, Mevalonate Pathway and its Intermediate Products in Placental Development and Preeclampsia
Current Molecular Pharmacology Preface
Current Neuropharmacology